Wall Street analyst estimates for Aspire Biopharma Holdings, Inc. (ASBP): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-08-13 | $-1.00 | ||
| 2026-05-15 | $-20.57 | ||
| 2026-03-30 | $-3.15 | ||
| 2025-11-14 | $-0.04 | ||
| 2025-08-13 | $-0.04 | ||
| 2025-05-14 | $-16.80 | ||
| 2025-04-07 | $-0.28 | ||
| 2024-11-14 | $-0.02 |
Valuation Ratios
| Price / Book | -37.44 |
| EV / EBITDA | -20.93 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | $6202 |
| Cost of Revenue | 0 | 0 | 0 | 0 | $6318 |
| Gross Profit | 0 | 0 | 0 | 0 | -$116 |
| Research & Development | 0 | 0 | $72050 | $144356 | $923914 |
| Selling, General & Admin | $27791 | $976345 | $1.3M | $1.1M | $18.4M |
| Operating Expenses | $25475 | $976345 | $1.3M | $1.2M | $19.4M |
| Operating Income | -$25480 | -$976345 | -$1.3M | -$1.2M | -$19.4M |
| EBITDA | -$25480 | -$976345 | $5.8M | -$1.2M | -$11.3M |
| Interest Expense | 0 | 0 | $8966 | $97988 | $8.5M |
| Pre-tax Income | -$25475 | $3.3M | $4.5M | -$1.3M | -$24.5M |
| Income Tax | 0 | 0 | 0 | $1013 | 0 |
| Net Income | -$25475 | $3.3M | $4.5M | -$1.3M | -$24.5M |
| EPS | $-0.04 | $3.72 | $9.31 | $-34.17 | $-16.38 |
| EPS (Diluted) | $-0.04 | $3.72 | $9.31 | $-34.17 | $-16.38 |
| Shares Outstanding (Diluted) | $682812 | $898437 | $479478 | $38339 | $1.5M |
Price
| Price | $8.58 |
| Market Cap | $1M |
| Exchange | NASDAQ |
| Country | US |
Related companies: ANNA · BOCN · CAUD · CHAA · CSLM · FIAC · GAMC
Explore sector: Healthcare · Biotechnology
More sections of ASBP: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks